

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinocyte differentiation (GO:0030216) | 9.84825329 |
| 2 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 8.83273946 |
| 3 | keratinocyte proliferation (GO:0043616) | 8.68658282 |
| 4 | molting cycle (GO:0042303) | 8.16108338 |
| 5 | hair cycle (GO:0042633) | 8.16108338 |
| 6 | peptide cross-linking (GO:0018149) | 7.74065988 |
| 7 | epidermal cell differentiation (GO:0009913) | 7.49394160 |
| 8 | multicellular organismal water homeostasis (GO:0050891) | 7.41139666 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 7.33817896 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.33817896 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 7.01443675 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.01443675 |
| 13 | epidermis development (GO:0008544) | 6.94157671 |
| 14 | intermediate filament organization (GO:0045109) | 6.61944493 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 6.59511857 |
| 16 | water homeostasis (GO:0030104) | 6.17988648 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.03345564 |
| 18 | tryptophan catabolic process (GO:0006569) | 5.97785893 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 5.97785893 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 5.97785893 |
| 21 | kynurenine metabolic process (GO:0070189) | 5.87612784 |
| 22 | bile acid biosynthetic process (GO:0006699) | 5.71988832 |
| 23 | surfactant homeostasis (GO:0043129) | 5.66300010 |
| 24 | tryptophan metabolic process (GO:0006568) | 5.63692736 |
| 25 | glyoxylate metabolic process (GO:0046487) | 5.60779538 |
| 26 | urea metabolic process (GO:0019627) | 5.51188787 |
| 27 | urea cycle (GO:0000050) | 5.51188787 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 5.49825009 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 5.47957433 |
| 30 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.43689075 |
| 31 | skin morphogenesis (GO:0043589) | 5.36670580 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 5.34734799 |
| 33 | cysteine metabolic process (GO:0006534) | 5.34618552 |
| 34 | detection of bacterium (GO:0016045) | 5.33873442 |
| 35 | regulation of protein activation cascade (GO:2000257) | 5.27254416 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 5.25334959 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.23480484 |
| 38 | protein carboxylation (GO:0018214) | 5.23480484 |
| 39 | regulation of fibrinolysis (GO:0051917) | 5.23456836 |
| 40 | complement activation, alternative pathway (GO:0006957) | 5.23103058 |
| 41 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.22325177 |
| 42 | intermediate filament cytoskeleton organization (GO:0045104) | 5.18890620 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 5.04716146 |
| 44 | intermediate filament-based process (GO:0045103) | 5.00882758 |
| 45 | lipoxygenase pathway (GO:0019372) | 4.99491035 |
| 46 | detection of other organism (GO:0098543) | 4.96871786 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.94969802 |
| 48 | regulation of complement activation (GO:0030449) | 4.93242405 |
| 49 | bile acid metabolic process (GO:0008206) | 4.86478252 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 4.81846970 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.77901284 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.75991914 |
| 53 | homocysteine metabolic process (GO:0050667) | 4.73231591 |
| 54 | reverse cholesterol transport (GO:0043691) | 4.72233548 |
| 55 | regulation of triglyceride catabolic process (GO:0010896) | 4.68516169 |
| 56 | linoleic acid metabolic process (GO:0043651) | 4.67865583 |
| 57 | chemical homeostasis within a tissue (GO:0048875) | 4.67834701 |
| 58 | lysine metabolic process (GO:0006553) | 4.67448010 |
| 59 | lysine catabolic process (GO:0006554) | 4.67448010 |
| 60 | positive regulation of epidermis development (GO:0045684) | 4.63747966 |
| 61 | regulation of cholesterol esterification (GO:0010872) | 4.60867599 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56931248 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 4.56931248 |
| 64 | macromolecular complex remodeling (GO:0034367) | 4.56931248 |
| 65 | cell-substrate junction assembly (GO:0007044) | 4.53441860 |
| 66 | amino-acid betaine metabolic process (GO:0006577) | 4.48631074 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 4.47872782 |
| 68 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.45568146 |
| 69 | phospholipid efflux (GO:0033700) | 4.45471690 |
| 70 | triglyceride homeostasis (GO:0070328) | 4.43283991 |
| 71 | acylglycerol homeostasis (GO:0055090) | 4.43283991 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 4.39502545 |
| 73 | negative regulation of sterol transport (GO:0032372) | 4.39502545 |
| 74 | negative regulation of interferon-gamma production (GO:0032689) | 4.35346102 |
| 75 | establishment of planar polarity (GO:0001736) | 4.31865745 |
| 76 | establishment of tissue polarity (GO:0007164) | 4.31865745 |
| 77 | keratinocyte development (GO:0003334) | 4.31569105 |
| 78 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.25750242 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 4.25433541 |
| 80 | ectoderm development (GO:0007398) | 4.24857002 |
| 81 | bile acid and bile salt transport (GO:0015721) | 4.20915817 |
| 82 | indolalkylamine metabolic process (GO:0006586) | 4.20177356 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 4.20044439 |
| 84 | glycine metabolic process (GO:0006544) | 4.18421182 |
| 85 | regulation of keratinocyte proliferation (GO:0010837) | 4.18099257 |
| 86 | regulation of natural killer cell differentiation (GO:0032823) | 4.16795099 |
| 87 | coenzyme catabolic process (GO:0009109) | 4.16547263 |
| 88 | cellular glucuronidation (GO:0052695) | 4.14983255 |
| 89 | glutamate metabolic process (GO:0006536) | 4.14049515 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 4.13625242 |
| 91 | imidazole-containing compound metabolic process (GO:0052803) | 4.12369100 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 4.11215410 |
| 93 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.10298396 |
| 94 | amine catabolic process (GO:0009310) | 4.09837854 |
| 95 | cellular biogenic amine catabolic process (GO:0042402) | 4.09837854 |
| 96 | fibrinolysis (GO:0042730) | 4.06960933 |
| 97 | serine family amino acid metabolic process (GO:0009069) | 4.05266610 |
| 98 | cholesterol efflux (GO:0033344) | 3.99487380 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 3.97659713 |
| 100 | ethanol oxidation (GO:0006069) | 3.94081538 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 3.91166658 |
| 102 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87850000 |
| 103 | arginine metabolic process (GO:0006525) | 3.86735495 |
| 104 | serine family amino acid biosynthetic process (GO:0009070) | 3.85942989 |
| 105 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.83569629 |
| 106 | drug catabolic process (GO:0042737) | 3.83192577 |
| 107 | regulation of cholesterol homeostasis (GO:2000188) | 3.80760114 |
| 108 | regulation of hair follicle development (GO:0051797) | 3.79797524 |
| 109 | low-density lipoprotein particle remodeling (GO:0034374) | 3.78592374 |
| 110 | ketone body metabolic process (GO:1902224) | 3.76366947 |
| 111 | phospholipid homeostasis (GO:0055091) | 3.74049541 |
| 112 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73729572 |
| 113 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.73034947 |
| 114 | glucuronate metabolic process (GO:0019585) | 3.67466313 |
| 115 | uronic acid metabolic process (GO:0006063) | 3.67466313 |
| 116 | complement activation (GO:0006956) | 3.66787688 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66284306 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66027730 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66027730 |
| 120 | complement activation, classical pathway (GO:0006958) | 3.65013306 |
| 121 | aldehyde catabolic process (GO:0046185) | 3.63710957 |
| 122 | positive regulation of hair follicle development (GO:0051798) | 3.63110744 |
| 123 | positive regulation of hair cycle (GO:0042635) | 3.63110744 |
| 124 | cholesterol homeostasis (GO:0042632) | 3.63086343 |
| 125 | positive regulation of lipid catabolic process (GO:0050996) | 3.62679015 |
| 126 | short-chain fatty acid metabolic process (GO:0046459) | 3.61837624 |
| 127 | acetyl-CoA metabolic process (GO:0006084) | 3.61481250 |
| 128 | protein activation cascade (GO:0072376) | 3.61431994 |
| 129 | carboxylic acid catabolic process (GO:0046395) | 3.61067459 |
| 130 | organic acid catabolic process (GO:0016054) | 3.61067459 |
| 131 | sterol homeostasis (GO:0055092) | 3.58139075 |
| 132 | blood coagulation, intrinsic pathway (GO:0007597) | 3.57258755 |
| 133 | negative regulation of lipase activity (GO:0060192) | 3.56501990 |
| 134 | protein-lipid complex assembly (GO:0065005) | 3.54490072 |
| 135 | cytolysis (GO:0019835) | 3.52636483 |
| 136 | cofactor catabolic process (GO:0051187) | 3.52170846 |
| 137 | plasma lipoprotein particle organization (GO:0071827) | 3.51986358 |
| 138 | regulation of plasminogen activation (GO:0010755) | 3.51506323 |
| 139 | acute-phase response (GO:0006953) | 3.48911010 |
| 140 | polarized epithelial cell differentiation (GO:0030859) | 3.48622240 |
| 141 | regulation of epidermis development (GO:0045682) | 3.48239267 |
| 142 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.40586678 |
| 143 | negative regulation of interleukin-17 production (GO:0032700) | 3.40286736 |
| 144 | sequestering of metal ion (GO:0051238) | 3.39069208 |
| 145 | regulation of monocyte chemotaxis (GO:0090025) | 3.33802382 |
| 146 | regulation of keratinocyte differentiation (GO:0045616) | 3.30106467 |
| 147 | protein localization to endosome (GO:0036010) | 3.26358920 |
| 148 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.23694416 |
| 149 | epithelium development (GO:0060429) | 3.20944568 |
| 150 | cell adhesion mediated by integrin (GO:0033627) | 3.14109395 |
| 151 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.12908117 |
| 152 | positive regulation of T cell chemotaxis (GO:0010820) | 3.11370404 |
| 153 | regulation of T cell chemotaxis (GO:0010819) | 3.11370404 |
| 154 | hair follicle morphogenesis (GO:0031069) | 3.04489689 |
| 155 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.01786853 |
| 156 | detection of external biotic stimulus (GO:0098581) | 2.99779341 |
| 157 | lateral sprouting from an epithelium (GO:0060601) | 2.98490600 |
| 158 | regulation of hair cycle (GO:0042634) | 2.97588371 |
| 159 | phosphatidylserine metabolic process (GO:0006658) | 2.91494205 |
| 160 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.86882357 |
| 161 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.84352890 |
| 162 | regulation of vitamin metabolic process (GO:0030656) | 2.82572202 |
| 163 | intestinal epithelial cell development (GO:0060576) | 2.81657380 |
| 164 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.80007782 |
| 165 | regulation of epidermal cell differentiation (GO:0045604) | 2.79427074 |
| 166 | hypotonic response (GO:0006971) | 2.73163550 |
| 167 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.64247899 |
| 168 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.58208788 |
| 169 | detection of biotic stimulus (GO:0009595) | 2.57158945 |
| 170 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.55901590 |
| 171 | atrioventricular valve morphogenesis (GO:0003181) | 2.55686811 |
| 172 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.49802825 |
| 173 | negative regulation of epidermis development (GO:0045683) | 2.48655217 |
| 174 | regulation of natural killer cell activation (GO:0032814) | 2.47781780 |
| 175 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.47405833 |
| 176 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47354836 |
| 177 | skin development (GO:0043588) | 2.47072725 |
| 178 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.44926369 |
| 179 | alditol phosphate metabolic process (GO:0052646) | 2.43773660 |
| 180 | cell communication involved in cardiac conduction (GO:0086065) | 2.40140959 |
| 181 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.37583840 |
| 182 | wound healing (GO:0042060) | 2.36893279 |
| 183 | epithelial cell proliferation (GO:0050673) | 2.36596645 |
| 184 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.35129570 |
| 185 | sphingosine metabolic process (GO:0006670) | 2.33033408 |
| 186 | ceramide biosynthetic process (GO:0046513) | 2.30310100 |
| 187 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.30177902 |
| 188 | epithelial cell-cell adhesion (GO:0090136) | 2.30104127 |
| 189 | hair cycle process (GO:0022405) | 2.27817082 |
| 190 | molting cycle process (GO:0022404) | 2.27817082 |
| 191 | positive regulation of protein export from nucleus (GO:0046827) | 2.27049542 |
| 192 | regulation of protein localization to cell surface (GO:2000008) | 2.26771012 |
| 193 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.23937887 |
| 194 | keratinization (GO:0031424) | 16.5156225 |
| 195 | establishment of skin barrier (GO:0061436) | 12.9290309 |
| 196 | desmosome organization (GO:0002934) | 12.5861808 |
| 197 | hemidesmosome assembly (GO:0031581) | 12.3629081 |
| 198 | regulation of water loss via skin (GO:0033561) | 11.5298672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.85410836 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.79009806 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.32187563 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.16385185 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.93267212 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.65786733 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.50718380 |
| 8 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 4.29677892 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.85566306 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.39394516 |
| 11 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.93177007 |
| 12 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.93177007 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.46080046 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23285999 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01730733 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1553534 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93721902 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92276142 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88463880 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86164452 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83830626 |
| 22 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.76623564 |
| 23 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76496622 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66150795 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.56021893 |
| 26 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.53348779 |
| 27 | ATF3_27146783_Chip-Seq_COLON_Human | 1.52693732 |
| 28 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.49390272 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35833235 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34882421 |
| 31 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33699378 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33595213 |
| 33 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.31955138 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27940253 |
| 35 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.27863980 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25276500 |
| 37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21018370 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19937663 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16668836 |
| 40 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15305718 |
| 41 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.14189460 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14123841 |
| 43 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13351905 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11092869 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10982245 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10645506 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07219989 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06431719 |
| 49 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03334119 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01061952 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00518817 |
| 52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99646212 |
| 53 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98871200 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98648948 |
| 55 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98003675 |
| 56 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96429617 |
| 57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96135075 |
| 58 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94518322 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93466681 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93413263 |
| 61 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93313931 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93102024 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88248689 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87008593 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86996773 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85301510 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.84637836 |
| 68 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83224034 |
| 69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82525150 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81927458 |
| 71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80437995 |
| 72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79375004 |
| 73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.77380283 |
| 74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.77031805 |
| 75 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76105982 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76023076 |
| 77 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75898925 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.75564550 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75428285 |
| 80 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.75020917 |
| 81 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.74555155 |
| 82 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.73916389 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73593475 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.73528999 |
| 85 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.72622343 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72176141 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72176141 |
| 88 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.70642751 |
| 89 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.70642751 |
| 90 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70627066 |
| 91 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.69876054 |
| 92 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.69091350 |
| 93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.68369328 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68120970 |
| 95 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67987673 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.67947357 |
| 97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.67806237 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.67390844 |
| 99 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.66912646 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.66352866 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66302142 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.66246245 |
| 103 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66147928 |
| 104 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66074039 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.64980429 |
| 106 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.64850653 |
| 107 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.64823976 |
| 108 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.64198887 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.63918244 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.63265452 |
| 111 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.63002020 |
| 112 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.62977801 |
| 113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.62835476 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.62709719 |
| 115 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.62046022 |
| 116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.62040058 |
| 117 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.61933690 |
| 118 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60947663 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60528111 |
| 120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.60360769 |
| 121 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.60298650 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59459193 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58188139 |
| 124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58109845 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57749952 |
| 126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57517604 |
| 127 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.56825308 |
| 128 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56248215 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.54398804 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54138446 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52730213 |
| 132 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52072566 |
| 133 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.52043365 |
| 134 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.51401702 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51147532 |
| 136 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.50573348 |
| 137 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49685631 |
| 138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49380117 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.49063334 |
| 140 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.48939394 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48900642 |
| 142 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48803548 |
| 143 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.48771455 |
| 144 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48603565 |
| 145 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.48444354 |
| 146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48204364 |
| 147 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48093896 |
| 148 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.48064966 |
| 149 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47144181 |
| 150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47051458 |
| 151 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.46813231 |
| 152 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46249655 |
| 153 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45804786 |
| 154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45712648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.86704105 |
| 2 | MP0005360_urolithiasis | 7.35035527 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.16972377 |
| 4 | MP0005365_abnormal_bile_salt | 5.89246167 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.78248309 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.82574888 |
| 7 | MP0003252_abnormal_bile_duct | 3.78901321 |
| 8 | MP0003941_abnormal_skin_development | 3.65365605 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.42912322 |
| 10 | MP0009840_abnormal_foam_cell | 3.12586684 |
| 11 | MP0005083_abnormal_biliary_tract | 3.04741599 |
| 12 | MP0005332_abnormal_amino_acid | 2.69375163 |
| 13 | MP0003195_calcinosis | 2.63434741 |
| 14 | MP0000762_abnormal_tongue_morphology | 2.63304678 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.62145514 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.54965810 |
| 17 | * MP0010771_integument_phenotype | 2.49171261 |
| 18 | MP0005409_darkened_coat_color | 2.35964423 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.34652292 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.26223185 |
| 21 | MP0000609_abnormal_liver_physiology | 2.07893825 |
| 22 | MP0000566_synostosis | 2.02299511 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.99393613 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.96999974 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.94557169 |
| 26 | MP0002254_reproductive_system_inflammat | 1.94417555 |
| 27 | MP0003878_abnormal_ear_physiology | 1.90851593 |
| 28 | MP0005377_hearing/vestibular/ear_phenot | 1.90851593 |
| 29 | MP0003868_abnormal_feces_composition | 1.78266361 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.76326964 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.73047947 |
| 32 | MP0003011_delayed_dark_adaptation | 1.46372016 |
| 33 | MP0001191_abnormal_skin_condition | 1.43275054 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42200366 |
| 35 | MP0001764_abnormal_homeostasis | 1.39241561 |
| 36 | MP0005451_abnormal_body_composition | 1.39052699 |
| 37 | MP0002234_abnormal_pharynx_morphology | 1.29765047 |
| 38 | MP0008260_abnormal_autophagy | 1.28983923 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.27335395 |
| 40 | * MP0000579_abnormal_nail_morphology | 1.26186156 |
| 41 | * MP0002796_impaired_skin_barrier | 1.25134559 |
| 42 | MP0009697_abnormal_copulation | 1.22058576 |
| 43 | MP0001851_eye_inflammation | 1.21695310 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.19919770 |
| 45 | MP0001849_ear_inflammation | 1.10999643 |
| 46 | MP0000598_abnormal_liver_morphology | 1.10250989 |
| 47 | MP0004272_abnormal_basement_membrane | 1.10228194 |
| 48 | MP0003186_abnormal_redox_activity | 1.08341425 |
| 49 | MP0000604_amyloidosis | 1.07910702 |
| 50 | MP0005647_abnormal_sex_gland | 1.06478839 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.03361605 |
| 52 | MP0004381_abnormal_hair_follicle | 0.98684645 |
| 53 | MP0009053_abnormal_anal_canal | 0.98025869 |
| 54 | MP0009764_decreased_sensitivity_to | 0.97143454 |
| 55 | MP0003315_abnormal_perineum_morphology | 0.96131207 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 0.94931407 |
| 57 | MP0002098_abnormal_vibrissa_morphology | 0.93206856 |
| 58 | MP0003303_peritoneal_inflammation | 0.93109043 |
| 59 | MP0005408_hypopigmentation | 0.91942136 |
| 60 | MP0002095_abnormal_skin_pigmentation | 0.91284173 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 0.90040163 |
| 62 | MP0009763_increased_sensitivity_to | 0.89725369 |
| 63 | MP0000678_abnormal_parathyroid_gland | 0.89098184 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 0.88509145 |
| 65 | MP0000647_abnormal_sebaceous_gland | 0.88127508 |
| 66 | MP0000858_altered_metastatic_potential | 0.88105745 |
| 67 | MP0010368_abnormal_lymphatic_system | 0.87780337 |
| 68 | MP0005275_abnormal_skin_tensile | 0.87028060 |
| 69 | MP0005257_abnormal_intraocular_pressure | 0.86285718 |
| 70 | MP0003950_abnormal_plasma_membrane | 0.84194704 |
| 71 | MP0000427_abnormal_hair_cycle | 0.82695855 |
| 72 | MP0003300_gastrointestinal_ulcer | 0.82589672 |
| 73 | MP0004043_abnormal_pH_regulation | 0.82408929 |
| 74 | MP0001661_extended_life_span | 0.80637624 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.79777270 |
| 76 | MP0008469_abnormal_protein_level | 0.78990022 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.78858503 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.77943920 |
| 79 | MP0010678_abnormal_skin_adnexa | 0.74895600 |
| 80 | MP0000627_abnormal_mammary_gland | 0.74841391 |
| 81 | MP0005670_abnormal_white_adipose | 0.74103751 |
| 82 | MP0000377_abnormal_hair_follicle | 0.73710177 |
| 83 | MP0002971_abnormal_brown_adipose | 0.69560862 |
| 84 | MP0008004_abnormal_stomach_pH | 0.69228855 |
| 85 | MP0000383_abnormal_hair_follicle | 0.67892448 |
| 86 | * MP0004885_abnormal_endolymph | 0.67204881 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.66122236 |
| 88 | MP0001243_abnormal_dermal_layer | 0.65558750 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.65294260 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.63979346 |
| 91 | MP0003329_amyloid_beta_deposits | 0.63396051 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.63383596 |
| 93 | MP0005248_abnormal_Harderian_gland | 0.63031327 |
| 94 | MP0009384_cardiac_valve_regurgitation | 0.62319601 |
| 95 | MP0001756_abnormal_urination | 0.61737704 |
| 96 | MP0004130_abnormal_muscle_cell | 0.61668002 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 0.61646753 |
| 98 | MP0001188_hyperpigmentation | 0.61492064 |
| 99 | MP0009785_altered_susceptibility_to | 0.60851370 |
| 100 | MP0005334_abnormal_fat_pad | 0.60643901 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.58762525 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 0.58600495 |
| 103 | MP0000467_abnormal_esophagus_morphology | 0.58590298 |
| 104 | MP0004947_skin_inflammation | 0.58091638 |
| 105 | * MP0002060_abnormal_skin_morphology | 0.56593224 |
| 106 | MP0003690_abnormal_glial_cell | 0.56546744 |
| 107 | * MP0005501_abnormal_skin_physiology | 0.56390220 |
| 108 | * MP0001216_abnormal_epidermal_layer | 0.55732416 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.55522915 |
| 110 | MP0003448_altered_tumor_morphology | 0.54808102 |
| 111 | MP0005535_abnormal_body_temperature | 0.53817880 |
| 112 | * MP0004264_abnormal_extraembryonic_tissu | 0.53670456 |
| 113 | MP0001881_abnormal_mammary_gland | 0.53272675 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.52510801 |
| 115 | * MP0003453_abnormal_keratinocyte_physiol | 0.52405496 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.52170699 |
| 117 | MP0005164_abnormal_response_to | 0.51084724 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.50532378 |
| 119 | MP0005448_abnormal_energy_balance | 0.48237366 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.47956763 |
| 121 | MP0002006_tumorigenesis | 0.47913488 |
| 122 | * MP0001784_abnormal_fluid_regulation | 0.46362881 |
| 123 | MP0000367_abnormal_coat/_hair | 0.45692321 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.44760767 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.44746900 |
| 126 | MP0003755_abnormal_palate_morphology | 0.44589907 |
| 127 | MP0005266_abnormal_metabolism | 0.44021224 |
| 128 | MP0002282_abnormal_trachea_morphology | 0.43343049 |
| 129 | MP0003045_fibrosis | 0.42944156 |
| 130 | MP0005023_abnormal_wound_healing | 0.42663176 |
| 131 | MP0001340_abnormal_eyelid_morphology | 0.42473296 |
| 132 | MP0005193_abnormal_anterior_eye | 0.42405683 |
| 133 | MP0005395_other_phenotype | 0.41930403 |
| 134 | MP0002177_abnormal_outer_ear | 0.41877687 |
| 135 | MP0003075_altered_response_to | 0.40643653 |
| 136 | MP0005464_abnormal_platelet_physiology | 0.40316296 |
| 137 | MP0002928_abnormal_bile_duct | 0.39591713 |
| 138 | MP0003091_abnormal_cell_migration | 0.39125749 |
| 139 | * MP0009931_abnormal_skin_appearance | 0.37012522 |
| 140 | MP0008789_abnormal_olfactory_epithelium | 0.36195503 |
| 141 | MP0001790_abnormal_immune_system | 0.35983317 |
| 142 | MP0005387_immune_system_phenotype | 0.35983317 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.35707421 |
| 144 | MP0005197_abnormal_uvea_morphology | 0.35454924 |
| 145 | MP0000685_abnormal_immune_system | 0.35448261 |
| 146 | MP0002896_abnormal_bone_mineralization | 0.35228957 |
| 147 | MP0003436_decreased_susceptibility_to | 0.35079352 |
| 148 | MP0000537_abnormal_urethra_morphology | 0.34811915 |
| 149 | MP0008873_increased_physiological_sensi | 0.34781850 |
| 150 | MP0003828_pulmonary_edema | 0.34413935 |
| 151 | MP0005166_decreased_susceptibility_to | 0.34274929 |
| 152 | MP0006082_CNS_inflammation | 0.33402499 |
| 153 | MP0005025_abnormal_response_to | 0.32929590 |
| 154 | MP0009672_abnormal_birth_weight | 0.32854329 |
| 155 | MP0002168_other_aberrant_phenotype | 0.32808520 |
| 156 | MP0005165_increased_susceptibility_to | 0.32358380 |
| 157 | MP0002089_abnormal_postnatal_growth/wei | 0.32329235 |
| 158 | MP0003724_increased_susceptibility_to | 0.31807119 |
| 159 | MP0008874_decreased_physiological_sensi | 0.31517904 |
| 160 | MP0002970_abnormal_white_adipose | 0.31395918 |
| 161 | MP0001765_abnormal_ion_homeostasis | 0.31384647 |
| 162 | MP0000470_abnormal_stomach_morphology | 0.31197876 |
| 163 | MP0006054_spinal_hemorrhage | 0.30556848 |
| 164 | MP0003763_abnormal_thymus_physiology | 0.30421638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Onycholysis (HP:0001806) | 8.86972632 |
| 2 | * Plantar hyperkeratosis (HP:0007556) | 8.06216363 |
| 3 | * Palmoplantar hyperkeratosis (HP:0000972) | 7.95087710 |
| 4 | Thick nail (HP:0001805) | 7.60079310 |
| 5 | * Palmar hyperkeratosis (HP:0010765) | 7.52457040 |
| 6 | Deep venous thrombosis (HP:0002625) | 7.36029526 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 7.18591130 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.12324019 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.50179031 |
| 10 | Xanthomatosis (HP:0000991) | 6.21895250 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 6.20909130 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 6.07733597 |
| 13 | Fragile nails (HP:0001808) | 6.04685905 |
| 14 | Milia (HP:0001056) | 5.96791323 |
| 15 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.92089558 |
| 16 | Increased IgE level (HP:0003212) | 5.88805758 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.53926429 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 5.44878983 |
| 19 | Complement deficiency (HP:0004431) | 5.39467801 |
| 20 | Hypotrichosis (HP:0001006) | 5.30412928 |
| 21 | Abnormality of secondary sexual hair (HP:0009888) | 5.15989410 |
| 22 | Abnormality of the axillary hair (HP:0100134) | 5.15989410 |
| 23 | * Alopecia of scalp (HP:0002293) | 5.12696096 |
| 24 | * Erythroderma (HP:0001019) | 4.99605056 |
| 25 | * Nail dystrophy (HP:0008404) | 4.99154359 |
| 26 | Erythema (HP:0010783) | 4.72608440 |
| 27 | Hypolipoproteinemia (HP:0010981) | 4.67418101 |
| 28 | Joint hemorrhage (HP:0005261) | 4.51536499 |
| 29 | Epidermoid cyst (HP:0200040) | 4.50551907 |
| 30 | Hyperammonemia (HP:0001987) | 4.50077651 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 4.46442782 |
| 32 | Parakeratosis (HP:0001036) | 4.44849741 |
| 33 | Woolly hair (HP:0002224) | 4.44035791 |
| 34 | Abnormal blistering of the skin (HP:0008066) | 4.39829213 |
| 35 | * Corneal erosion (HP:0200020) | 4.37828889 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.36119790 |
| 37 | Ridged nail (HP:0001807) | 4.28211781 |
| 38 | Hyperglycinemia (HP:0002154) | 4.27074940 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26779405 |
| 40 | Pili torti (HP:0003777) | 4.26439580 |
| 41 | * Oral leukoplakia (HP:0002745) | 4.24980081 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 4.21450227 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18371418 |
| 44 | Ketosis (HP:0001946) | 4.15567945 |
| 45 | Fat malabsorption (HP:0002630) | 4.07958906 |
| 46 | Ectropion (HP:0000656) | 4.02078746 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.01195768 |
| 48 | Abnormality of methionine metabolism (HP:0010901) | 4.00414755 |
| 49 | Abnormality of complement system (HP:0005339) | 3.93445900 |
| 50 | Hyperglycinuria (HP:0003108) | 3.89029967 |
| 51 | Atrophic scars (HP:0001075) | 3.87415887 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82406285 |
| 53 | Abnormality of glycine metabolism (HP:0010895) | 3.82406285 |
| 54 | Abnormal hair laboratory examination (HP:0003328) | 3.76535822 |
| 55 | * Palmoplantar keratoderma (HP:0000982) | 3.74029938 |
| 56 | Hypoglycemic coma (HP:0001325) | 3.72501683 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70580560 |
| 58 | Lip pit (HP:0100267) | 3.52064838 |
| 59 | Hypercholesterolemia (HP:0003124) | 3.51732604 |
| 60 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.49241624 |
| 61 | Sparse scalp hair (HP:0002209) | 3.47988082 |
| 62 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47012921 |
| 63 | Gangrene (HP:0100758) | 3.35304499 |
| 64 | * Sparse eyelashes (HP:0000653) | 3.33899597 |
| 65 | * Hypohidrosis (HP:0000966) | 3.27220693 |
| 66 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23711448 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.19376252 |
| 68 | Abnormality of the salivary glands (HP:0010286) | 3.16749860 |
| 69 | Hyperbilirubinemia (HP:0002904) | 3.11704436 |
| 70 | Steatorrhea (HP:0002570) | 3.09447892 |
| 71 | Follicular hyperkeratosis (HP:0007502) | 3.08131643 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06947745 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 3.05285152 |
| 74 | Myocardial infarction (HP:0001658) | 2.99495516 |
| 75 | Spontaneous abortion (HP:0005268) | 2.98143147 |
| 76 | Blepharitis (HP:0000498) | 2.97197926 |
| 77 | Ketoacidosis (HP:0001993) | 2.96439545 |
| 78 | Pustule (HP:0200039) | 2.95194325 |
| 79 | Natal tooth (HP:0000695) | 2.94270987 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.93410618 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.85841232 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 2.85800805 |
| 83 | Vascular calcification (HP:0004934) | 2.81630649 |
| 84 | Selective tooth agenesis (HP:0001592) | 2.78466701 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.74845095 |
| 86 | Hypochromic microcytic anemia (HP:0004840) | 2.68853405 |
| 87 | Skin nodule (HP:0200036) | 2.67501066 |
| 88 | Gout (HP:0001997) | 2.66262850 |
| 89 | Metabolic acidosis (HP:0001942) | 2.61114078 |
| 90 | Spastic diplegia (HP:0001264) | 2.57699436 |
| 91 | Neonatal onset (HP:0003623) | 2.54089935 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.53406015 |
| 93 | Anonychia (HP:0001798) | 2.48673450 |
| 94 | Hyperhidrosis (HP:0000975) | 2.44238973 |
| 95 | Lethargy (HP:0001254) | 2.43042206 |
| 96 | Dry hair (HP:0011359) | 2.42396082 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 2.42136147 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.42136147 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 2.41049412 |
| 100 | Conjunctival hamartoma (HP:0100780) | 2.40734999 |
| 101 | Hypoplastic labia majora (HP:0000059) | 2.40446812 |
| 102 | Pruritus (HP:0000989) | 2.40114684 |
| 103 | Cholelithiasis (HP:0001081) | 2.37971633 |
| 104 | Glomerulonephritis (HP:0000099) | 2.37426669 |
| 105 | Esophageal varix (HP:0002040) | 2.37194339 |
| 106 | Malnutrition (HP:0004395) | 2.36994058 |
| 107 | Advanced eruption of teeth (HP:0006288) | 2.35894956 |
| 108 | Mitral stenosis (HP:0001718) | 2.35161704 |
| 109 | Hypoglycemic seizures (HP:0002173) | 2.34879197 |
| 110 | Amyloidosis (HP:0011034) | 2.31025399 |
| 111 | Dehydration (HP:0001944) | 2.30441208 |
| 112 | Acanthocytosis (HP:0001927) | 2.27234679 |
| 113 | Hypoplasia of dental enamel (HP:0006297) | 2.25536231 |
| 114 | Irritability (HP:0000737) | 2.25433813 |
| 115 | Laryngomalacia (HP:0001601) | 2.22257855 |
| 116 | Gingival bleeding (HP:0000225) | 2.21797322 |
| 117 | Popliteal pterygium (HP:0009756) | 2.19969834 |
| 118 | Abnormality of the neuromuscular junction (HP:0003398) | 2.19830304 |
| 119 | Fatigable weakness (HP:0003473) | 2.19830304 |
| 120 | Xerostomia (HP:0000217) | 2.19758652 |
| 121 | Corneal dystrophy (HP:0001131) | 2.18810099 |
| 122 | Hydroxyprolinuria (HP:0003080) | 2.18629352 |
| 123 | Abnormality of proline metabolism (HP:0010907) | 2.18629352 |
| 124 | Abnormality of the labia majora (HP:0012881) | 2.16481067 |
| 125 | Oligodontia (HP:0000677) | 2.15414954 |
| 126 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14962639 |
| 127 | Cholecystitis (HP:0001082) | 2.14037913 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 2.14037913 |
| 129 | Fragile skin (HP:0001030) | 2.13299398 |
| 130 | Sensorimotor neuropathy (HP:0007141) | 2.12432244 |
| 131 | Pterygium (HP:0001059) | 2.12193232 |
| 132 | * Carious teeth (HP:0000670) | 2.11779477 |
| 133 | Menorrhagia (HP:0000132) | 2.11760077 |
| 134 | Brittle hair (HP:0002299) | 2.10155342 |
| 135 | Pancreatitis (HP:0001733) | 2.08841875 |
| 136 | Hemorrhage of the eye (HP:0011885) | 2.08180427 |
| 137 | Cerebral edema (HP:0002181) | 2.07326304 |
| 138 | Rickets (HP:0002748) | 2.06685914 |
| 139 | Late onset (HP:0003584) | 2.06043327 |
| 140 | Thrombophlebitis (HP:0004418) | 2.05106025 |
| 141 | * Absent hair (HP:0002298) | 2.04483496 |
| 142 | * Abnormality of nail color (HP:0100643) | 11.4774986 |
| 143 | Brushfield spots (HP:0001088) | 1.99168424 |
| 144 | Enlarged kidneys (HP:0000105) | 1.98515115 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.97749947 |
| 146 | Ankyloglossia (HP:0010296) | 1.97683030 |
| 147 | Right ventricular cardiomyopathy (HP:0011663) | 1.96364587 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.96002239 |
| 149 | Vomiting (HP:0002013) | 1.95176201 |
| 150 | Hypophosphatemic rickets (HP:0004912) | 1.95108357 |
| 151 | Opisthotonus (HP:0002179) | 1.94068846 |
| 152 | Slow-growing hair (HP:0002217) | 1.92942052 |
| 153 | Abnormality of hair growth rate (HP:0011363) | 1.92942052 |
| 154 | * Skin ulcer (HP:0200042) | 1.91522121 |
| 155 | Abnormal cartilage morphology (HP:0002763) | 1.91116393 |
| 156 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89961017 |
| 157 | * Absent eyelashes (HP:0000561) | 1.89828601 |
| 158 | Lack of skin elasticity (HP:0100679) | 1.88831186 |
| 159 | Increased purine levels (HP:0004368) | 1.87124390 |
| 160 | Hyperuricemia (HP:0002149) | 1.87124390 |
| 161 | Nephritis (HP:0000123) | 1.86690181 |
| 162 | Abnormality of iron homeostasis (HP:0011031) | 1.86643853 |
| 163 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85554419 |
| 164 | * Abnormality of the fingernails (HP:0001231) | 1.84445860 |
| 165 | Aplasia cutis congenita (HP:0001057) | 1.84309537 |
| 166 | Alkalosis (HP:0001948) | 1.82648935 |
| 167 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82259530 |
| 168 | Back pain (HP:0003418) | 1.80889927 |
| 169 | Axonal loss (HP:0003447) | 1.78664908 |
| 170 | Poikilocytosis (HP:0004447) | 1.74659087 |
| 171 | Abnormality of the Achilles tendon (HP:0005109) | 1.72721498 |
| 172 | Hypergammaglobulinemia (HP:0010702) | 1.70355764 |
| 173 | Split foot (HP:0001839) | 1.68941749 |
| 174 | Ventricular tachycardia (HP:0004756) | 1.66610956 |
| 175 | Dry skin (HP:0000958) | 1.66074800 |
| 176 | Paralysis (HP:0003470) | 1.63814881 |
| 177 | Septate vagina (HP:0001153) | 1.63558317 |
| 178 | Acanthosis nigricans (HP:0000956) | 1.59755315 |
| 179 | * Multifactorial inheritance (HP:0001426) | 1.58404087 |
| 180 | Breast hypoplasia (HP:0003187) | 1.58379772 |
| 181 | Melanocytic nevus (HP:0000995) | 1.58041476 |
| 182 | Neurofibrillary tangles (HP:0002185) | 1.54562471 |
| 183 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.53730082 |
| 184 | Conical tooth (HP:0000698) | 1.53485016 |
| 185 | Curly hair (HP:0002212) | 1.49856553 |
| 186 | * Urticaria (HP:0001025) | 1.49353271 |
| 187 | * Furrowed tongue (HP:0000221) | 1.49205925 |
| 188 | Abnormality of permanent molar morphology (HP:0011071) | 1.48859519 |
| 189 | Abnormality of the dental root (HP:0006486) | 1.48859519 |
| 190 | Taurodontia (HP:0000679) | 1.48859519 |
| 191 | Abnormality of the gastric mucosa (HP:0004295) | 1.48582004 |
| 192 | Abnormality of oral frenula (HP:0000190) | 1.47811963 |
| 193 | Sepsis (HP:0100806) | 1.45296806 |
| 194 | Premature loss of primary teeth (HP:0006323) | 1.43088666 |
| 195 | Nasolacrimal duct obstruction (HP:0000579) | 1.43063816 |
| 196 | Labial hypoplasia (HP:0000066) | 1.42790695 |
| 197 | Abnormality of glycolipid metabolism (HP:0010969) | 1.41656401 |
| 198 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.41656401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.98241949 |
| 2 | ERN1 | 4.78705871 |
| 3 | SIK1 | 4.43818382 |
| 4 | FGFR4 | 4.28238115 |
| 5 | TGFBR1 | 3.27056400 |
| 6 | MAP3K9 | 2.99466775 |
| 7 | STK24 | 2.85117597 |
| 8 | TAOK3 | 2.74250231 |
| 9 | LATS1 | 2.73411603 |
| 10 | TRIB3 | 2.72921560 |
| 11 | PKN2 | 2.58174021 |
| 12 | MST1R | 2.49662653 |
| 13 | ERBB4 | 2.48541834 |
| 14 | PIM2 | 2.48004031 |
| 15 | ARAF | 2.36014423 |
| 16 | INSRR | 2.22085446 |
| 17 | PTK6 | 1.95387299 |
| 18 | MAP2K4 | 1.89117302 |
| 19 | PIK3CG | 1.80479925 |
| 20 | DDR2 | 1.66750838 |
| 21 | MAPK11 | 1.60300220 |
| 22 | EPHB1 | 1.58168049 |
| 23 | TYK2 | 1.53517489 |
| 24 | NTRK1 | 1.51324834 |
| 25 | PRPF4B | 1.44106070 |
| 26 | FLT3 | 1.41453872 |
| 27 | NME2 | 1.39957373 |
| 28 | FRK | 1.39412323 |
| 29 | MST4 | 1.32380749 |
| 30 | IKBKB | 1.31327059 |
| 31 | MAP3K7 | 1.30365525 |
| 32 | EPHA3 | 1.29834801 |
| 33 | FGFR2 | 1.29361433 |
| 34 | STK38L | 1.28082679 |
| 35 | DAPK2 | 1.26342956 |
| 36 | MAP3K3 | 1.20012652 |
| 37 | NEK9 | 1.19005601 |
| 38 | MET | 1.15916760 |
| 39 | ABL2 | 1.15524560 |
| 40 | MOS | 1.15166069 |
| 41 | JAK2 | 1.14475528 |
| 42 | ERBB2 | 1.14257347 |
| 43 | TBK1 | 1.06753764 |
| 44 | JAK1 | 1.05611090 |
| 45 | RIPK1 | 1.02195246 |
| 46 | MAP3K12 | 1.01287209 |
| 47 | LMTK2 | 1.01227051 |
| 48 | CDK12 | 1.00217934 |
| 49 | GRK7 | 0.99161760 |
| 50 | MAP3K10 | 0.98755034 |
| 51 | PAK4 | 0.98527318 |
| 52 | TRPM7 | 0.97341726 |
| 53 | PRKAA2 | 0.97110099 |
| 54 | CDK6 | 0.96539735 |
| 55 | GRK6 | 0.95126204 |
| 56 | MAP3K14 | 0.94588490 |
| 57 | FGFR3 | 0.93895304 |
| 58 | KSR2 | 0.93620269 |
| 59 | DYRK1B | 0.93379391 |
| 60 | FER | 0.93229779 |
| 61 | FGR | 0.93034167 |
| 62 | MAP2K3 | 0.92162823 |
| 63 | PTK2 | 0.90491277 |
| 64 | MATK | 0.89099823 |
| 65 | CDC42BPA | 0.85660808 |
| 66 | KDR | 0.83486183 |
| 67 | TAOK2 | 0.82893023 |
| 68 | IRAK3 | 0.80725908 |
| 69 | PRKCZ | 0.80289050 |
| 70 | GSK3A | 0.77743993 |
| 71 | JAK3 | 0.77538466 |
| 72 | MAP3K11 | 0.76655114 |
| 73 | MAPK15 | 0.75564183 |
| 74 | BLK | 0.75549214 |
| 75 | BMPR2 | 0.74701345 |
| 76 | TESK1 | 0.73846170 |
| 77 | STK10 | 0.72625983 |
| 78 | MAPK4 | 0.71806914 |
| 79 | CAMK1D | 0.71386090 |
| 80 | EPHA2 | 0.71181889 |
| 81 | PBK | 0.70701270 |
| 82 | BMX | 0.70127839 |
| 83 | TGFBR2 | 0.68990549 |
| 84 | MAP2K6 | 0.67941251 |
| 85 | PDGFRB | 0.66832232 |
| 86 | RET | 0.63434210 |
| 87 | MAPK12 | 0.63234477 |
| 88 | LATS2 | 0.61183115 |
| 89 | MAP2K1 | 0.59354269 |
| 90 | PDGFRA | 0.58545948 |
| 91 | CSK | 0.57752079 |
| 92 | SGK3 | 0.57548042 |
| 93 | ERBB3 | 0.57456379 |
| 94 | PRKACG | 0.56334858 |
| 95 | CAMK2G | 0.56107091 |
| 96 | EPHB2 | 0.53110028 |
| 97 | PDPK1 | 0.51280937 |
| 98 | PINK1 | 0.51147787 |
| 99 | MAPKAPK2 | 0.49887347 |
| 100 | SIK3 | 0.49662873 |
| 101 | MTOR | 0.49652115 |
| 102 | PRKAA1 | 0.49247195 |
| 103 | FGFR1 | 0.48123972 |
| 104 | STK3 | 0.46915993 |
| 105 | MAP3K2 | 0.46437354 |
| 106 | MAPKAPK3 | 0.46426324 |
| 107 | IKBKE | 0.46269121 |
| 108 | MAP3K1 | 0.45382213 |
| 109 | TIE1 | 0.45286440 |
| 110 | MAP2K2 | 0.44473929 |
| 111 | WNK1 | 0.44176421 |
| 112 | BRAF | 0.42099439 |
| 113 | IGF1R | 0.40943092 |
| 114 | CHUK | 0.40770762 |
| 115 | IRAK4 | 0.40219339 |
| 116 | CAMK1G | 0.40061684 |
| 117 | MAPK7 | 0.39084645 |
| 118 | IRAK2 | 0.37865478 |
| 119 | MAP3K6 | 0.37744428 |
| 120 | SMG1 | 0.37201886 |
| 121 | PRKD2 | 0.35651429 |
| 122 | ZAP70 | 0.34731245 |
| 123 | MAP3K5 | 0.34689759 |
| 124 | LRRK2 | 0.33523914 |
| 125 | EGFR | 0.33361439 |
| 126 | CSNK1G1 | 0.32795442 |
| 127 | KSR1 | 0.31813746 |
| 128 | RPS6KA2 | 0.30714450 |
| 129 | ROCK2 | 0.30641896 |
| 130 | PRKCQ | 0.30622288 |
| 131 | PAK3 | 0.30547051 |
| 132 | RPS6KB1 | 0.30175044 |
| 133 | MAP3K13 | 0.30135495 |
| 134 | SGK2 | 0.29748625 |
| 135 | ICK | 0.29677403 |
| 136 | PRKCI | 0.29531115 |
| 137 | NEK6 | 0.27151889 |
| 138 | BCR | 0.26664909 |
| 139 | CSF1R | 0.25907890 |
| 140 | DMPK | 0.25849022 |
| 141 | PDK1 | 0.25738030 |
| 142 | PIK3CA | 0.25002527 |
| 143 | STK38 | 0.24612966 |
| 144 | SGK223 | 0.23401396 |
| 145 | SGK494 | 0.23401396 |
| 146 | ABL1 | 0.22663702 |
| 147 | IRAK1 | 0.21495234 |
| 148 | PKN1 | 0.21483725 |
| 149 | TAOK1 | 0.20765749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.42816608 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63107170 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.42898371 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35161877 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04725670 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75495627 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67127512 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66755052 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57978132 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48821701 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48103944 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36523555 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22090771 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.20236494 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.11558868 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11223312 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09209251 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.06000009 |
| 19 | VEGF signaling pathway_Homo sapiens_hsa04370 | 2.04251891 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96612468 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92981791 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91913426 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91578298 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90000523 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89427871 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83582856 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81985216 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.77820691 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.77129206 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73710703 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72463081 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70322555 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66644417 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64670698 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63122395 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.61326947 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58183660 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54269288 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53814480 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.52122629 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49861283 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47581655 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.43816412 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.43679888 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42099897 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.41906931 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40573462 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35814181 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33844546 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32731394 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32095672 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31023897 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27627231 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23845189 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22554882 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20556578 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19484255 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19454692 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19121294 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18318912 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16514982 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14999520 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14614471 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14224501 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 1.13824962 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 1.13657823 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09954500 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08163439 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07899475 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 1.07673999 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07023680 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 1.04750275 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 1.04600662 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03974158 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02140820 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.99917581 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99760108 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98908809 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98198097 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97460197 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97439925 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95500833 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95121826 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.94896996 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93998413 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93581353 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89963241 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89588797 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88785139 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88540816 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.85813249 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84951665 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84289915 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83687584 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83305048 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82036550 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.80906945 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.78326024 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.78199901 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76930929 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76650425 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75999754 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75091827 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74683600 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73068001 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72528332 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72024009 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71794100 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71622562 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.71394693 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69763943 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67737227 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66831821 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65613137 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65006503 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64826331 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64444905 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.59403031 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58894180 |
| 120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58484456 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58262511 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.56264688 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54074433 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52536872 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51762892 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51238786 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48512740 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.48038455 |
| 129 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46941057 |
| 130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46868602 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46714723 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46281978 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.45902306 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.45770116 |
| 135 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42640426 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42482048 |
| 137 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41416960 |
| 138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40715241 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40586667 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39954672 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.34857655 |
| 142 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31784054 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.30339867 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27629630 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23703021 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18663379 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17325160 |
| 148 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11427014 |
| 149 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08500055 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04349502 |
| 151 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2122494 |
| 152 | Mineral absorption_Homo sapiens_hsa04978 | -0.1999282 |
| 153 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1957308 |
| 154 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1833834 |
| 155 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1828992 |
| 156 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1623364 |
| 157 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1494880 |
| 158 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1473459 |
| 159 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1338084 |
| 160 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1266606 |
| 161 | Bladder cancer_Homo sapiens_hsa05219 | -0.1133629 |
| 162 | Amoebiasis_Homo sapiens_hsa05146 | -0.1032084 |
| 163 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1032080 |
| 164 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1001332 |
| 165 | Hepatitis C_Homo sapiens_hsa05160 | -0.0968000 |
| 166 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0801017 |
| 167 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0750960 |
| 168 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0694674 |
| 169 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0616037 |
| 170 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0455058 |
| 171 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0167389 |

